NCT00313729View on ClinicalTrials.gov

Temozolomide in Treating Patients With Low-Grade Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

September 25, 2014

Study Completion Date

June 12, 2017

Conditions
CNS Tumor, Adult
Interventions
DRUG

temozolomide

Chemotherapy

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00313729 - Temozolomide in Treating Patients With Low-Grade Glioma | Biotech Hunter | Biotech Hunter